HAVCR2 and neoplasm: We also observed intensive interactions of CD274-PDCD1, PDCD1LG2-PDCD1, and LGALS9-HAVCR2 between iCAFs and tumor-infiltrating T cells (Fig. 5C), which are well-characterized immune checkpoint axes, suggesting their immunosuppressive capability on T cells.